Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

50.15
Delayed Data
As of Dec 07
 -1.20 / -2.34%
Today’s Change
29.50
Today|||52-Week Range
59.41
+6.50%
Year-to-Date
SECTOR
Process Industries
INDUSTRY
Chemicals: Specialty
MARKET CAP
$1.7B

Company Description

Cambrex Corp. engages in the provisio ofproducts, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies its products and services to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.

Contact Information

Cambrex Corp.
One Meadowlands Plaza
East Rutherford New Jersey 07073
P:(201) 804-3000
Investor Relations:
(201) 804-3037

Employees

Shareholders

Mutual fund holders53.76%
Other institutional47.10%
Individual stakeholders2.70%

Top Executives

Steven M. KloskPresident, Chief Executive Officer & Director
Shawn P. CavanaghChief Operating Officer & Executive Vice President
Gregory P. SargenChief Financial Officer & Executive Vice President
James G. FarrellVice President & Controller
Samantha M. HanleySecretary, Vice President & General Counsel